The DOI matches its Crossref record.
Renal Pathology in Fabry Disease
Abstract
Fabry disease is an X-linked recessive lysosomal storage disease that is caused by deficient activity of the lysosomal enzyme α-galactosidase A (α-Gal A), an enzyme that cleaves terminal α-galactosyl residues. This deficiency results in progressive lysosomal accumulation of glycosphingolipid with terminal α-galactosyl residues, particularly globotriaosylceramide (Gb3). Gb3 accumulates in many cells, particularly in renal epithelial cells, endothelial cells, pericytes, vascular smooth muscle cells, cardiomyocytes, and neurons of the autonomic nervous system (1). The genetic defect occurs in all cell types, but involvement differs greatly among different organs and cell types. This heterogeneity likely reflects different rates of sphingolipid metabolism. Thus the minimum threshold requirement for α-Gal A activity to prevent Gb3 accumulation varies across cell types due to the type and amount of substrates that are recycled by the different cells (2). Renal lesions are found in both hemizygous (male) and heterozygous (female) patients. Renal symptoms in the latter are typically milder and delayed by 2 to 3 decades, but there is considerable variability (3). The variability is likely the result of the random nature of X inactivation, resulting in considerable variability in α-Gal A activity among carriers and (at least theoretically) within one carrier individual among various tissues or regions of a single tissue. Light Microscopy The renal pathology of Fabry disease was first described just over 50 years ago and has been the subject of numerous case reports and series since then (4). Glomeruli on light microscopy show hypertrophic glomerular visceral epithelial cells (podocytes) distended with foamy appearing vacuoles, mesangial widening, and varying degrees of glomerular obsolescence (Figure 1, A and B). Within the glomerulus, the largest amount of lipid material is seen in podocytes, followed by the parietal epithelial, mesangial, and glomerular endothelial cells. With disease progression, glomeruli exhibit mesangial widening, in some cases segmental glomerulosclerosis, and ultimately global glomerulosclerosis. Figure 1. : Renal pathology in Fabry disease. (A) Glomerulus showing extensive inclusion bodies of glycolipid in podocytes (arrowhead), and mild mesangial widening (PAS stain; magnification, ×80). (B) Plastic embedded tissue showing in-site deposition of glycolipid in glomerular podocytes (arrowhead; toluidine blue stain; magnification, ×80). (C) Plastic embedded renal tissue demonstrating glycolipid inclusion bodies in distal tubules (asterisk), with relative sparing of proximal tubules, and interstitial fibrosis (toluidine blue stain; magnification, ×80). (D) Deposition of glycolipid in endothelial cells of peritubular capillaries (asterisk; toluidine blue stain; magnification, ×200). (E) Urine showing vacuolated urinary epithelial cells (oval fat bodies) in a Fabry patient (Papanicolaou stain; magnification, ×160). Figure modified with permission from Branton et al. (14).Vacuolation is also present in the capillary endothelium and distal tubular epithelial cells, including those of Henle’s loop and the collecting duct, particularly intercalated cells (Figure 1C), and less commonly in proximal tubular epithelial cells. Vascular involvement includes deposition in capillary, arterial, and arteriolar endothelial cells, pericytes, and smooth muscle cells (Figure 1D and Figure 2B). In severe disease, there is progressive tubular atrophy, interstitial fibrosis, and varying amounts of interstitial fibrosis. Figure 2. : Electron microscopy in Fabry disease. (A) Electron microscopy of a renal biopsy obtained from a 26-yr-old male Fabry patient demonstrates accumulation of storage material within the secondary lysosomes of podocytes and glomerular parietal epithelial cells. There is focal foot process effacement. There is free glycolipid in the urinary space and a thickened Bowman’s capsule (magnification, ×3760). (Inset) Higher magnification demonstrates enlarged lysosomes within a podocyte and a mixture of lamellated membrane structures and small vesicles in the glomerular parietal epithelium (magnification, ×11,200). (B) Electron microscopy of renal biopsy obtained from a male Fabry patient shows a small artery, with lysosomal storage located within endothelial cells (E) and smooth muscle cells (S) (magnification, ×3800). (Inset) Higher magnification of the endothelial cell cytoplasm demonstrates enlarged secondary lysosomes packed with storage material, which has a somewhat heterogeneous appearance (magnification, ×11,200).In general, making the diagnosis of Fabry’s disease on a needle biopsy is not difficult, particularly if electron microscopy is performed. There is somewhat more difficulty in determining whether the disease has progressed or stabilized over a period of time, because damage is not uniform in all glomeruli or all areas of the tubulointerstitium. Therefore, clinical research protocols th
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925
Stenvinkel, P., Carrero, J. J. A. A., Axelsson, J., Lindholm, B., Heimbu[Combining Diaeresis]rger, O., & Massy, Z. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03670807 · Cited by 561
Kumada, M., Kihara, S., Ouchi, N., Kobayashi, H., Okamoto, Y., Ohashi, K., Maeda, K., Nagaretani, H., Kishida, K., Maeda, N., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127953.98131.ed · Cited by 555
Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis
Sattar, N., Wannamethee, G., Sarwar, N., Tchernova, J., Cherry, L., Wallace, A. M., Danesh, J., & Whincup, P. H. (2006) · Circulation · doi:10.1161/circulationaha.106.618918 · Cited by 403
Adiponectin and Coronary Heart Disease: The Strong Heart Study
Lindsay, R. S., Resnick, H. E., Zhu, J., Tun, M. L., Howard, B. V., Zhang, Y., Yeh, J., & Best, L. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000153090.21990.8c · Cited by 169
Metadata
- Authors
- Alroy, J., Sabnis, S., & Kopp, J. B.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2002-06
- Volume
- 13
- Issue
- suppl_2
- Pages
- S134-S138
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2140375980
- Cited by
- 243
- References
- 0
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Renal Pathology in Fabry Disease. https://app.cochat.ai/papers/10.1097/01.asn.0000016684.07368.75
- The paper
- Alroy, J., Sabnis, S., & Kopp, J. B. (2002). Renal Pathology in Fabry Disease. Journal of the American Society of Nephrology. https://doi.org/10.1097/01.asn.0000016684.07368.75
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.